Caris Life Sciences Showcases Data on KRAS Mutations in Patients With Non-Small Cell Lung and Pancreatic Cancer at ASCO20 Virtual Scientific Program
Retrieved on:
Friday, May 29, 2020
The poster is titled, "Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC)."
Key Points:
- The poster is titled, "Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC)."
- Caris will present additional data from studies highlighting the distinct molecular landscapes of patients across several cancer types, including mesothelioma and gastroesophageal cancers.
- Caris Life Sciences is a leading innovator in molecular science focused on fulfilling the promise of precision medicine through quality and innovation.
- Headquartered in Irving, Texas, Caris Life Sciences offers services throughout the U.S., Europe, Asia and other international markets.